S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
30 Days of MarketBeat All Access Free (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
30 Days of MarketBeat All Access Free (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
30 Days of MarketBeat All Access Free (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
30 Days of MarketBeat All Access Free (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NYSE:PRGO

Perrigo (PRGO) Stock Forecast, Price & News

$32.25
-0.43 (-1.32%)
(As of 09/22/2023 ET)
Compare
Today's Range
$32.15
▼
$32.78
50-Day Range
$32.25
▼
$39.94
52-Week Range
$30.78
▼
$41.44
Volume
1.20 million shs
Average Volume
1.53 million shs
Market Capitalization
$4.37 billion
P/E Ratio
N/A
Dividend Yield
3.38%
Price Target
$46.67
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Perrigo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
44.7% Upside
$46.67 Price Target
Short Interest
Healthy
3.40% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.93
Upright™ Environmental Score
News Sentiment
0.84mentions of Perrigo in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
17.31%
From $2.60 to $3.05 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.22 out of 5 stars

Medical Sector

11th out of 963 stocks

Pharmaceutical Preparations Industry

3rd out of 458 stocks

See Top Rated MarketRank™ Stocks Here

PRGO stock logo

About Perrigo (NYSE:PRGO) Stock

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women's health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada. This segment offers its products under Burt's Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands. Consumer Self-Care International segment comprises consumer self-care product categories outside the U.S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe. In addition, the company offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

PRGO Price History

PRGO Stock News Headlines

September 19, 2023 | americanbankingnews.com
Traders Purchase High Volume of Call Options on Perrigo (NYSE:PRGO)
September 14, 2023 | barrons.com
Perrigo Co. PLC
September 24, 2023 | Chaikin Analytics (Ad)
"This Could be the Biggest Stock Story of 2023"
A.I. is set to create $7 trillion in new wealth but most investors are buying the wrong stocks. Learn what Wall Street insiders are buying here.
September 11, 2023 | finance.yahoo.com
Perrigo Announces Leadership Update
September 8, 2023 | marketwatch.com
Perrigo Co. PLC stock rises Friday, outperforms market
September 8, 2023 | stocknews.com
Relay Therapeutics (RLAY) vs. Perrigo Company (PRGO): Which Pharma Stock Holds Better Upside Potential?
September 7, 2023 | finance.yahoo.com
Perrigo (PRGO) Down 11.7% Since Last Earnings Report: Can It Rebound?
September 5, 2023 | thestreet.com
Perrigo (PRGO) Stock Declined on AstraZeneca Drug Rights Deal
September 24, 2023 | Chaikin Analytics (Ad)
"This Could be the Biggest Stock Story of 2023"
A.I. is set to create $7 trillion in new wealth but most investors are buying the wrong stocks. Learn what Wall Street insiders are buying here.
August 31, 2023 | finance.yahoo.com
PRGO: Strong 2Q results; reaffirming $46 target
August 30, 2023 | seekingalpha.com
The Prognosis For Perrigo
August 24, 2023 | finance.yahoo.com
Perrigo to Attend Upcoming Consumer Investor Conferences
August 16, 2023 | marketwatch.com
Perrigo Co. PLC stock falls Wednesday, underperforms market
August 15, 2023 | marketwatch.com
Perrigo Co. PLC stock outperforms market despite losses on the day
August 10, 2023 | seekingalpha.com
Perrigo Company plc 2023 Q2 - Results - Earnings Call Presentation
August 8, 2023 | finance.yahoo.com
Perrigo (PRGO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
August 8, 2023 | finance.yahoo.com
Perrigo (PRGO) Beats on Q2 Earnings & Sales, Reiterates '23 View
August 8, 2023 | markets.businessinsider.com
Perrigo Company plc Q2 Earnings Summary
August 8, 2023 | finance.yahoo.com
Perrigo: Q2 Earnings Snapshot
August 7, 2023 | markets.businessinsider.com
Here's what Wall Street expects from Perrigo Company's earnings report
August 1, 2023 | ca.finance.yahoo.com
PIG.SG - Perrigo Co PLC
July 28, 2023 | seekingalpha.com
PRGO Perrigo Company plc
July 25, 2023 | finance.yahoo.com
Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
July 21, 2023 | finance.yahoo.com
With a Big Catalyst in Hand, Is Perrigo Company a Buy?
July 15, 2023 | msn.com
FDA Approves First-Ever OTC Birth Control Pill
July 14, 2023 | finance.yahoo.com
Perrigo (PRGO) Gets FDA Nod for First OTC Birth Control Pill
July 14, 2023 | investorplace.com
PRGO Stock Alert: Perrigo Climbs on Landmark FDA Birth Control Decision
See More Headlines
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Company Calendar

Last Earnings
8/08/2023
Ex-Dividend for 9/19 Dividend
8/31/2023
Dividend Payable
9/19/2023
Today
9/24/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:PRGO
CUSIP
71429010
CIK
1585364
Web
www.perrigo.com
Phone
(531) 709-4000
Fax
269-673-9128
Employees
8,900
Year Founded
1887

Price Target and Rating

Average Stock Price Forecast
$46.67
High Stock Price Forecast
$49.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+44.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
12.40
P/E Growth
N/A
Net Income
$-140,600,000.00
Net Margins
-1.22%
Pretax Margin
0.19%
Return on Equity
6.79%
Return on Assets
2.98%

Debt

Debt-to-Equity Ratio
0.84
Current Ratio
2.62
Quick Ratio
1.52

Sales & Book Value

Annual Sales
$4.45 billion
Price / Sales
0.98
Cash Flow
$4.59 per share
Price / Cash Flow
7.02
Book Value
$35.96 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
135,400,000
Free Float
134,449,000
Market Cap
$4.37 billion
Optionable
Optionable
Beta
0.81

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Eduardo Guarita Bezerra (Age 48)
    Exec. VP & CFO
    Comp: $1.46M
  • Ms. Kyle L. Hanson (Age 58)
    Exec. VP, Gen. Counsel & Corp. Sec.
    Comp: $729.87k
  • Mr. Svend AndersenMr. Svend Andersen (Age 61)
    Exec. VP & Pres of Consumer Self-Care International
    Comp: $1.17M
  • Mr. James E. Dillard IIIMr. James E. Dillard III (Age 59)
    Exec. VP & Pres of Consumer Self-Care Americas
    Comp: $1.15M
  • Mr. Patrick Lockwood-Taylor
    Pres, CEO & Director
  • Mr. Ronald C. JanishMr. Ronald C. Janish (Age 57)
    Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain
  • Mr. Shannon Hukill
    Sr. Director of Technical Operations
  • Mr. Thomas M. FarringtonMr. Thomas M. Farrington (Age 66)
    Chief Information Officer & Exec. VP
  • Ms. Alison Ives (Age 42)
    Exec. VP & Chief Scientific Officer
  • Mr. Bradley Joseph
    VP of Global Investor Relations & Corp. Communications

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PRGO Stock - Frequently Asked Questions

Should I buy or sell Perrigo stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRGO shares.
View PRGO analyst ratings or view top-rated stocks.

What is Perrigo's stock price forecast for 2023?

3 brokers have issued 1 year target prices for Perrigo's shares. Their PRGO share price forecasts range from $43.00 to $49.00. On average, they predict the company's stock price to reach $46.67 in the next year. This suggests a possible upside of 44.7% from the stock's current price.
View analysts price targets for PRGO or view top-rated stocks among Wall Street analysts.

How have PRGO shares performed in 2023?

Perrigo's stock was trading at $34.09 at the start of the year. Since then, PRGO stock has decreased by 5.4% and is now trading at $32.25.
View the best growth stocks for 2023 here.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 5,450,000 shares, an increase of 19.3% from the July 31st total of 4,570,000 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 4.9 days.
View Perrigo's Short Interest.

When is Perrigo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our PRGO earnings forecast.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) announced its quarterly earnings results on Tuesday, August, 8th. The company reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.54 by $0.09. The company had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a negative net margin of 1.22% and a positive trailing twelve-month return on equity of 6.79%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.43 earnings per share.
Read the conference call transcript.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Wednesday, August 2nd. Shareholders of record on Friday, September 1st will be given a dividend of $0.273 per share on Tuesday, September 19th. This represents a $1.09 annualized dividend and a dividend yield of 3.39%. The ex-dividend date of this dividend is Thursday, August 31st.
Read our dividend analysis for PRGO.

What ETFs hold Perrigo's stock?

ETFs with the largest weight of Perrigo (NYSE:PRGO) stock in their portfolio include Invesco Pharmaceuticals ETF (PJP), SPDR S&P Pharmaceuticals ETF (XPH), AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG), Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL), ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL), VanEck Pharmaceutical ETF (PPH), iShares U.S. Pharmaceuticals ETF (IHE) and Alpha Intelligent - Large Cap Value ETF (AILV).

Is Perrigo a good dividend stock?

Perrigo (NYSE:PRGO) pays an annual dividend of $1.09 per share and currently has a dividend yield of 3.39%.
Read our dividend analysis for PRGO.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $2.50-$2.70 for the period, compared to the consensus earnings per share estimate of $2.61. The company issued revenue guidance of $4.76 billion-$4.94 billion, compared to the consensus revenue estimate of $4.83 billion.

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo Chief Executive Officer Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.32%), Dimensional Fund Advisors LP (4.90%), Wolf Hill Capital Management LP (3.96%), State Street Corp (3.20%), Cooke & Bieler LP (2.60%) and Coho Partners Ltd. (2.59%). Insiders that own company stock include Bradley A Alford, Geoffrey M Parker, Grainne Quinn, James E Dillard III, Murray S Kessler, Raymond Silcock, Richard S Sorota, Rolf A Classon, Ronald Craig Janish, Svend Andersen, Theodore R Samuels II, Thomas Farrington and Todd W Kingma.
View institutional ownership trends.

How do I buy shares of Perrigo?

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $32.25.

How much money does Perrigo make?

Perrigo (NYSE:PRGO) has a market capitalization of $4.37 billion and generates $4.45 billion in revenue each year. The company earns $-140,600,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis.

How many employees does Perrigo have?

The company employs 8,900 workers across the globe.

Does Perrigo have any subsidiaries?
The following companies are subsidiares of Perrigo: 010414 UK Limited, 251211 UK Limited, Abtei Omega Pharma GmbH, Aco Hud Nordic AB, Adriatic BST Trgovina in Storitve D.o.o., Adriatic Distribution doo Beograd, Agis Industries, Algorithmics Risk Management Limited, Arginet Investments and Property (2003) Ltd., Athena Neurosciences LLC, Aurora Pharmaceuticals Pty Ltd, Biover NV, Blue Wolf Global Limited, Bluewolf International Limited, Brunel Healthcare Manufacturing Limited, CP Kayak Holdings Inc., CanNegev Ltd, Chefaro Ireland Designated Activity Company, Cinetic Laboratories Argentina SA, Cleversafe UK Limited, Cosmediet - Biotechnie SAS, Despharma Kft., Elan Corporation, Elan Europa Finance S.á r.l., Elan International Services Limited, Elan Pharmaceuticals LLC, Fera Pharmaceuticals, Galpharm Healthcare Limited, Galpharm International, Galpharm International Limited, Geiss Destin & Dunn, Gelcaps Exportadora de Mexico S.A. de C.V., Gr8ness LLC, HRA Pharma, Habsont Unlimited Company, Heartbeat Experts Limited, IBM GF international Treasury Company, IBM International Treasury Services Unlimited Company, IBM Netherlands Treasury B.V., Interdelta S.A., International Business Machines Limited, Irish Biosciences Venture Capital Fund, JB Laboratories, JLR Pharma S.A., Jaico R.D.P. NV, Jewel Consumer Care Pvt. Ltd., Kazmira LLC, Kenexa Global Recruitment Services Limited, Kenexa Quorum Holdings Limited, Kenexa Technology LLC, Kiteacre Limited, L. Perrigo Company, Laboratoire de la Mer SAS, Laboratoires Omega Pharma France SAS, Laboratorios DIBA S.A., Laboratorios Diba, Luxembourg Investment Company 289 Sàrl, MH (UK) Limited, Medgenix Benelux NV, Monksland Holdings B.V., Naturwohl Pharma GmbH, ORION Laboratories, Oce Bio BV, Oce-Bio Nederland B.V., Omega Alpharm Cyprus Ltd., Omega Pharma, Omega Pharma AS, Omega Pharma Australia Pty Ltd, Omega Pharma Austria Healthcare GmbH, Omega Pharma Baltics SIA, Omega Pharma Belgium NV, Omega Pharma Capital NV, Omega Pharma Deutschland GmbH, Omega Pharma GmbH, Omega Pharma Hellas SA Health and Beauty Products, Omega Pharma Hungary Kft., Omega Pharma Innovation & Development NV, Omega Pharma International NV, Omega Pharma Limited, Omega Pharma Luxembourg SarL, Omega Pharma Manufacturing GmbH & Co. KG, Omega Pharma Manufacturing Verwaltungs GmbH, Omega Pharma Nederland B.V., Omega Pharma Trading NV, Omega Pharma s.r.o., Omega Teknika Designated Activity Company, OmegaLabs (Pty) Ltd, Oniqua Europe Limited, Optevia Limited, Orion Laboratories (NZ) Ltd., Orion Laboratories PTY Limited, P-Direct NL B.V., P2C Inc., PBM Canada Holdings LLC, PBM China Holdings LLC, PBM Foods LLC, PBM Holdings LLC, PBM International Holdings LLC, PBM Mexico Holdings LLC, PBM Nutritionals LLC, PBM Products, PBM Products LLC, PBM Products Mexico S de R.L. de C.V., PMI Branded Pharmaceuticals Inc., Paddock Laboratories, Paracelsia Pharma GmbH, Perrigo Asia Holding Company Ltd., Perrigo Australian Holding Company II PTY Limited, Perrigo Bulgaria OOD, Perrigo China Business Trust, Perrigo China Business Trustee LLC, Perrigo Company, Perrigo Company Charitable Foundation, Perrigo Company of Tennessee, Perrigo Company plc, Perrigo Corporation Designated Activity Company, Perrigo Danmark A/S, Perrigo Diabetes Care LLC, Perrigo Direct Inc., Perrigo España SA, Perrigo Europe Invest NV, Perrigo Finance (US) LLC, Perrigo Finance Unlimited Company, Perrigo Florida Inc., Perrigo France SAS, Perrigo Global Holdings Inc., Perrigo Holding NV, Perrigo Holdings Unlimited Company, Perrigo International Finance Designated Activity Company, Perrigo International Holdings II Inc., Perrigo International Holdings LLC, Perrigo International Inc., Perrigo International Insurance Limited, Perrigo Ireland 1 Designated Activity Company, Perrigo Ireland 10 Unlimited Company, Perrigo Ireland 11 DAC, Perrigo Ireland 12 Designated Activity Company, Perrigo Ireland 13 Designated Activity Company, Perrigo Ireland 2 Designated Activity Company, Perrigo Ireland 3 Designated Activity Company, Perrigo Ireland 4 Unlimited Company, Perrigo Ireland 5 Unlimited Company, Perrigo Ireland 6 Unlimited Company, Perrigo Ireland 7 Designated Activity Company, Perrigo Ireland 8 Designated Activity Company, Perrigo Ireland 9 Unlimited Company, Perrigo Ireland Holding Company B.V., Perrigo Ireland Management Designated Activity Company, Perrigo Israel Enterprises & Investments Ltd., Perrigo Israel Holdings II B.V., Perrigo Israel Opportunities II Ltd., Perrigo Israel Trading Limited Partnership, Perrigo Italia S.r.l, Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi, Perrigo LLC, Perrigo Laboratories India Private Limited, Perrigo Management Company, Perrigo Mexico Holding S.A. de C.V., Perrigo Mexico Investment Holdings LLC, Perrigo Netherlands B.V., Perrigo Netherlands Finco 1 Coöperatief U.A., Perrigo Netherlands Finco 2 B.V., Perrigo Netherlands International Partnership C.V., Perrigo New York Inc., Perrigo Norge AS, Perrigo Oral Health Care Holdings Inc., Perrigo Pharma Holding Nederland BV, Perrigo Pharma International Designated Activity Company, Perrigo Pharma Limited, Perrigo Poland Sp.z.o.o, Perrigo Portugal LDA, Perrigo Research & Development Company, Perrigo România S.R.L., Perrigo Sales Corporation, Perrigo Science Eight Unlimited Company, Perrigo Science One Designated Activity Company, Perrigo Suomi Oy, Perrigo Sverige AB, Perrigo Trading (Shanghai) Co. Ltd., Perrigo UK Acquisition Limited, Perrigo UK Finco Limited Partnership, Perrigo Ukraine LLC, Perrigo Ventures Limited Partnership, Perrigo de Mexico S.A. de C.V., Perrigo do Brasil Farmaceutica Ltda., Pharma Clal (1983) Ltd., Promontory Financial Group (UK) Limited, Quimica y Farmacia S.A. de C.V., Ranir, Ranir (Holdings) Limited, Ranir Changshu Oral Care CO. Ltd., Ranir Global Holdings LLC, Ranir LLC, Ranir Limited, Resilient Systems Europe Limited, Richard Bittner AG, Rosemont Pharmaceuticals, Rubicon Healthcare Holdings Pty Ltd, SPSS Limited, Samenwerkende Apothekers Nederland B.V., ScarAway, Silverpop Systems Limited, Simpler Consulting Limited, Solent Dental Company Limited, Solent Oral Care Limited, Sterling Commerce (UK) Limited, The Analytic Sciences Corporation Limited, The Learning Pharmacy Limited, The Weather Channel Global Media Limited, Totalcare International Corp, Transitive Corporation Limited, Transitive Limited, Truven Health Analytics UK Limited, Velcera, Weather Services International Limited, Wrafton Laboratories, Wrafton Laboratories Limited, Zibo Xinhua - Perrigo Pharmaceutical Company Ltd., i2 Holdings Limited, i2 Intermediate Holdings Limited, and i2 Limited.
Read More
How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The official website for the company is www.perrigo.com. The company can be reached via phone at (531) 709-4000, via email at bradley.joseph@perrigo.com, or via fax at 269-673-9128.

This page (NYSE:PRGO) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -